NCT06291636

Brief Summary

Readmission to the intensive care unit (ICU) results in increased consumption of medical resources and costs, and has been proposed as a marker for quality of care. ICU readmission rates have been estimated at 4 to 14% and different risk factors have been proposed by various studies Readmitted patients mostly carry poor prognosis compared to newly admitted ones, in addition to the bad psychological impact for both patient and his family

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
994

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 20, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

12 months

First QC Date

February 20, 2024

Last Update Submit

February 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Length of hospital and ICU stay and Cause of readmission

    From the database of Mansour university hospital registration, we collect the following data about all adult patients (\>18 years) with acute respiratory failure and admitted to Mansoura University chest department and its related ICU with at least one readmission from start of January 2023 till the end of December 2023:

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with acute respiratory failure (either type I or type II)

You may qualify if:

  • \- Age 18 years or more
  • Patient with acute respiratory failure (either type I or type II) who were treated with high flow nasal cannula, non-invasive ventilation or invasive mechanical ventilation
  • A readmission event was recorded if the same patient ID was present in the same year; therefore, the follow-up period was different for each patient enrolled
  • Readmission is considered early if it occurs within 72 h and late if after 72 h of previous admission in the same hospital.

You may not qualify if:

  • All patient with missed or incomplete data
  • All patients died after first admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tamer Awad Elsayed

Al Mansurah, Dakhlia, 050, Egypt

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of chest medicine

Study Record Dates

First Submitted

February 20, 2024

First Posted

March 4, 2024

Study Start

January 1, 2023

Primary Completion

December 31, 2023

Study Completion

January 20, 2024

Last Updated

March 4, 2024

Record last verified: 2024-02

Locations